NPPES file of Aug 9, 2026

Oksana Hamidi, D.O.

Endocrinology, Diabetes & Metabolism Physician · Dallas, TX

Oksana Hamidi, D.O. is an endocrinology, diabetes & metabolism physician with a practice address in Dallas, Texas, and NPI 1629331400, issued on Jun 18, 2012. Check the license (Texas R6410, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1629331400
Name
Oksana Hamidi
Credential
D.O.
Primary taxonomy
Endocrinology, Diabetes & Metabolism Physician 207RE0101X
License number
R6410 TX
Self-reported in NPPES; status is on the state search
Practice location
2001 Inwood RD, Dallas, TX 75390
Phone
(214) 645-2800
Enumerated
Jun 18, 2012
Record last updated
May 15, 2019 (not updated in 7 years: call before relying on the address or phone)
Fax
(214) 645-2828
Medicare enrollment
Enrolled (PECOS I20180628000812); accepts Medicare assignment
Medical or professional school
Midwestern University, Chicago College Of Osteopathic Med, 2012
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 2001 Inwood RD

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Tayo Addo, MDInterventional Cardiology Physician1457328403
  2. David Aguilar, MDCardiovascular Disease Physician1326128695
  3. Shibbi Alexander, AGACNP, FNPNurse Practitioner1639673551
  4. Mirza Baig, M.D.Vascular Surgery Physician1023275526
  5. Natalie Bavli, M.D.Hematology (Internal Medicine) Physician1295115574
  6. Alyssa Bean, MS, RD, LDRegistered Dietitian1942915038

Verify Oksana Hamidi in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersTexas Medical Board
    Search for license R6410
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Texas license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

65% fewer Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024

933 Medicare Part D claims for 141 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D.

  1. Oksana Hamidi933
  2. Specialty average2,630

Most prescribed

  1. Hydrocortisone167 claims
  2. Levothyroxine Sodium74 claims
  3. Mounjaro51 claims
  4. Synthroid34 claims
  5. Fludrocortisone Acetate32 claims
  6. Testosterone31 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 74.6 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score56.1
  2. Costout of 100 · 30%59.2
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $36,325.71

38 payments; by number, the most common kind was food and beverage; the largest payer was Recordati_rare_diseases_inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Oksana Hamidi$36,326
  2. Specialty average$5,742

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. University OF Texas Southwestern Medical Center AT DallasDallas, TX

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Oksana Hamidi among 743 endocrinology, diabetes & metabolism physician records in Texas

Oksana Hamidi, D.O. is one of 743 endocrinology, diabetes & metabolism physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2012, is newer than 69% of them.

  • NPI issued2012 · 69% of these records are older, 27% newer
  • In a Medicare fileYes · 87% of these records are
  • In the CMS Doctors and Clinicians fileYes · 75% of these records are
  • Graduated2012 · median 2004 among the 560 with a school on file
  • Record last updated2019 · 50% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RE0101X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Endocrinology, Diabetes & Metabolism Physician providers in Texas

There are 743 endocrinology, diabetes & metabolism physician records in Texas.

The 8 endocrinology, diabetes & metabolism physician records with the nearest ZIP codes

  1. Perry Bickel, M.D.Dallas, TX 753901285651737
  2. Alberto Cabo Chan, MDDallas, TX 753901750314449
  3. Abhimanyu Garg, MDDallas, TX 753901871562355
  4. Ildiko Lingvay, MDDallas, TX 753901447216916
  5. Naim Maalouf, M.D.Dallas, TX 753901811956188
  6. David McFadden, M.D.Dallas, TX 753901962458174
  7. Michael McPhaul, MDDallas, TX 753901730146168
  8. Luigi Meneghini, M.D.Dallas, TX 753901245295831

Common questions

What is Oksana Hamidi, D.O.'s NPI number?

Oksana Hamidi, D.O.'s National Provider Identifier (NPI) is 1629331400, issued on Jun 18, 2012. An NPI identifies a provider in billing; it is not a license.

Where is Oksana Hamidi, D.O. located?

The NPPES record lists a practice address at 2001 Inwood RD, Dallas, TX, 75390. Phone: (214) 645-2800. Providers update this record themselves, so call before visiting.

How can I verify Oksana Hamidi, D.O.'s license?

NPPES lists Texas license number R6410, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Oksana Hamidi, D.O. prescribe under Medicare Part D?

In 2024, Oksana Hamidi, D.O. had 933 Medicare Part D claims for 141 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.

What is Oksana Hamidi, D.O.'s MIPS final score?

The 2023 MIPS final score is 74.6 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.